Application of metabolomics technologies toward cancer prognosis and therapy

Giang Hoang, Sunag Udupa, Quy Hoa Le Thi

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Altered metabolism is one of the defining features of cancer. Since the discovery of the Warburg effect in 1924, research into the metabolic aspects of cancer has been reinvigorated over the past decade. Metabolomics is an invaluable tool for gaining insights into numerous biochemical processes including those related to cancer metabolism and metabolic aspects of other diseases. The combination of untargeted and targeted metabolomics approaches has greatly facilitated the discovery of many cancer biomarkers with prognostic potential. Using mass spectrometry-based stable isotope-resolved metabolomics (SIRM) with isotopic labeling, a powerful tool used in pathway analysis, researchers have discovered novel cancer metabolic pathways and metabolic targets for therapeutic application. Metabolomics technologies provide invaluable metabolic insights reflecting cancer progression in coordination with genomics and proteomics aspects. The systematic study of metabolite levels in the metabolome and their dynamics within a biological organism has been, in recent years, applied across a wide range of fields. Metabolomics technologies have been applied to both early clinical trials and pre-clinical research in several essential aspects of human health. This chapter will give an overview of metabolomics technologies and their application in the discovery of novel pathways using isotopic labeled and non-labeled metabolomics.

Original languageEnglish (US)
Title of host publicationInternational Review of Cell and Molecular Biology
EditorsDavid C. Montrose, Lorenzo Galluzzi
PublisherElsevier Inc.
Pages191-223
Number of pages33
ISBN (Print)9780128184066
DOIs
StatePublished - Jan 1 2019

Publication series

NameInternational Review of Cell and Molecular Biology
Volume347
ISSN (Print)1937-6448

Fingerprint

Metabolomics
Technology
Neoplasms
Metabolism
Therapeutics
Biochemical Phenomena
Metabolome
Tumor Biomarkers
Metabolites
Genomics
Metabolic Networks and Pathways
Research
Isotopes
Proteomics
Labeling
Mass spectrometry
Mass Spectrometry
Research Personnel
Health
Clinical Trials

Keywords

  • Cancer metabolism
  • Glucose metabolism
  • Glutamine metabolism
  • Isotopic labeling
  • Metabolomics technologies

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Hoang, G., Udupa, S., & Le Thi, Q. H. (2019). Application of metabolomics technologies toward cancer prognosis and therapy. In D. C. Montrose, & L. Galluzzi (Eds.), International Review of Cell and Molecular Biology (pp. 191-223). (International Review of Cell and Molecular Biology; Vol. 347). Elsevier Inc.. https://doi.org/10.1016/bs.ircmb.2019.07.003

Application of metabolomics technologies toward cancer prognosis and therapy. / Hoang, Giang; Udupa, Sunag; Le Thi, Quy Hoa.

International Review of Cell and Molecular Biology. ed. / David C. Montrose; Lorenzo Galluzzi. Elsevier Inc., 2019. p. 191-223 (International Review of Cell and Molecular Biology; Vol. 347).

Research output: Chapter in Book/Report/Conference proceedingChapter

Hoang, G, Udupa, S & Le Thi, QH 2019, Application of metabolomics technologies toward cancer prognosis and therapy. in DC Montrose & L Galluzzi (eds), International Review of Cell and Molecular Biology. International Review of Cell and Molecular Biology, vol. 347, Elsevier Inc., pp. 191-223. https://doi.org/10.1016/bs.ircmb.2019.07.003
Hoang G, Udupa S, Le Thi QH. Application of metabolomics technologies toward cancer prognosis and therapy. In Montrose DC, Galluzzi L, editors, International Review of Cell and Molecular Biology. Elsevier Inc. 2019. p. 191-223. (International Review of Cell and Molecular Biology). https://doi.org/10.1016/bs.ircmb.2019.07.003
Hoang, Giang ; Udupa, Sunag ; Le Thi, Quy Hoa. / Application of metabolomics technologies toward cancer prognosis and therapy. International Review of Cell and Molecular Biology. editor / David C. Montrose ; Lorenzo Galluzzi. Elsevier Inc., 2019. pp. 191-223 (International Review of Cell and Molecular Biology).
@inbook{be44a0d217d14c7a93e44fdd007d6c76,
title = "Application of metabolomics technologies toward cancer prognosis and therapy",
abstract = "Altered metabolism is one of the defining features of cancer. Since the discovery of the Warburg effect in 1924, research into the metabolic aspects of cancer has been reinvigorated over the past decade. Metabolomics is an invaluable tool for gaining insights into numerous biochemical processes including those related to cancer metabolism and metabolic aspects of other diseases. The combination of untargeted and targeted metabolomics approaches has greatly facilitated the discovery of many cancer biomarkers with prognostic potential. Using mass spectrometry-based stable isotope-resolved metabolomics (SIRM) with isotopic labeling, a powerful tool used in pathway analysis, researchers have discovered novel cancer metabolic pathways and metabolic targets for therapeutic application. Metabolomics technologies provide invaluable metabolic insights reflecting cancer progression in coordination with genomics and proteomics aspects. The systematic study of metabolite levels in the metabolome and their dynamics within a biological organism has been, in recent years, applied across a wide range of fields. Metabolomics technologies have been applied to both early clinical trials and pre-clinical research in several essential aspects of human health. This chapter will give an overview of metabolomics technologies and their application in the discovery of novel pathways using isotopic labeled and non-labeled metabolomics.",
keywords = "Cancer metabolism, Glucose metabolism, Glutamine metabolism, Isotopic labeling, Metabolomics technologies",
author = "Giang Hoang and Sunag Udupa and {Le Thi}, {Quy Hoa}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/bs.ircmb.2019.07.003",
language = "English (US)",
isbn = "9780128184066",
series = "International Review of Cell and Molecular Biology",
publisher = "Elsevier Inc.",
pages = "191--223",
editor = "Montrose, {David C.} and Lorenzo Galluzzi",
booktitle = "International Review of Cell and Molecular Biology",

}

TY - CHAP

T1 - Application of metabolomics technologies toward cancer prognosis and therapy

AU - Hoang, Giang

AU - Udupa, Sunag

AU - Le Thi, Quy Hoa

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Altered metabolism is one of the defining features of cancer. Since the discovery of the Warburg effect in 1924, research into the metabolic aspects of cancer has been reinvigorated over the past decade. Metabolomics is an invaluable tool for gaining insights into numerous biochemical processes including those related to cancer metabolism and metabolic aspects of other diseases. The combination of untargeted and targeted metabolomics approaches has greatly facilitated the discovery of many cancer biomarkers with prognostic potential. Using mass spectrometry-based stable isotope-resolved metabolomics (SIRM) with isotopic labeling, a powerful tool used in pathway analysis, researchers have discovered novel cancer metabolic pathways and metabolic targets for therapeutic application. Metabolomics technologies provide invaluable metabolic insights reflecting cancer progression in coordination with genomics and proteomics aspects. The systematic study of metabolite levels in the metabolome and their dynamics within a biological organism has been, in recent years, applied across a wide range of fields. Metabolomics technologies have been applied to both early clinical trials and pre-clinical research in several essential aspects of human health. This chapter will give an overview of metabolomics technologies and their application in the discovery of novel pathways using isotopic labeled and non-labeled metabolomics.

AB - Altered metabolism is one of the defining features of cancer. Since the discovery of the Warburg effect in 1924, research into the metabolic aspects of cancer has been reinvigorated over the past decade. Metabolomics is an invaluable tool for gaining insights into numerous biochemical processes including those related to cancer metabolism and metabolic aspects of other diseases. The combination of untargeted and targeted metabolomics approaches has greatly facilitated the discovery of many cancer biomarkers with prognostic potential. Using mass spectrometry-based stable isotope-resolved metabolomics (SIRM) with isotopic labeling, a powerful tool used in pathway analysis, researchers have discovered novel cancer metabolic pathways and metabolic targets for therapeutic application. Metabolomics technologies provide invaluable metabolic insights reflecting cancer progression in coordination with genomics and proteomics aspects. The systematic study of metabolite levels in the metabolome and their dynamics within a biological organism has been, in recent years, applied across a wide range of fields. Metabolomics technologies have been applied to both early clinical trials and pre-clinical research in several essential aspects of human health. This chapter will give an overview of metabolomics technologies and their application in the discovery of novel pathways using isotopic labeled and non-labeled metabolomics.

KW - Cancer metabolism

KW - Glucose metabolism

KW - Glutamine metabolism

KW - Isotopic labeling

KW - Metabolomics technologies

UR - http://www.scopus.com/inward/record.url?scp=85071059643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071059643&partnerID=8YFLogxK

U2 - 10.1016/bs.ircmb.2019.07.003

DO - 10.1016/bs.ircmb.2019.07.003

M3 - Chapter

SN - 9780128184066

T3 - International Review of Cell and Molecular Biology

SP - 191

EP - 223

BT - International Review of Cell and Molecular Biology

A2 - Montrose, David C.

A2 - Galluzzi, Lorenzo

PB - Elsevier Inc.

ER -